pubmed-article:15492322 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C0085542 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C0118168 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C0730345 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15492322 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
pubmed-article:15492322 | pubmed:issue | 18 | lld:pubmed |
pubmed-article:15492322 | pubmed:dateCreated | 2004-11-2 | lld:pubmed |
pubmed-article:15492322 | pubmed:abstractText | Microalbuminuria is associated with increased risk of cardiovascular events. We assessed whether therapeutic intervention aimed at lowering urinary albumin excretion would reduce cardiovascular events in microalbuminuric subjects (15 to 300 mg/24 hours). | lld:pubmed |
pubmed-article:15492322 | pubmed:language | eng | lld:pubmed |
pubmed-article:15492322 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15492322 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15492322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15492322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15492322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15492322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15492322 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15492322 | pubmed:month | Nov | lld:pubmed |
pubmed-article:15492322 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:van BovenAd... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:JanssenWilber... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:de JongPaul... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:de ZeeuwDickD | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:DiercksGilles... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:HillegeHans... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:VoorsAdriaan... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:AsselbergsFol... | lld:pubmed |
pubmed-article:15492322 | pubmed:author | pubmed-author:Prevention... | lld:pubmed |
pubmed-article:15492322 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:15492322 | pubmed:day | 2 | lld:pubmed |
pubmed-article:15492322 | pubmed:volume | 110 | lld:pubmed |
pubmed-article:15492322 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15492322 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15492322 | pubmed:pagination | 2809-16 | lld:pubmed |
pubmed-article:15492322 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:meshHeading | pubmed-meshheading:15492322... | lld:pubmed |
pubmed-article:15492322 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15492322 | pubmed:articleTitle | Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. | lld:pubmed |
pubmed-article:15492322 | pubmed:affiliation | Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands. | lld:pubmed |
pubmed-article:15492322 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15492322 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15492322 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15492322 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15492322 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15492322 | lld:pubmed |